Phuong N. Huynh

Array ( [id] => 13209223 [patent_doc_number] => 10118968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof [patent_app_type] => utility [patent_app_number] => 12/649179 [patent_app_country] => US [patent_app_date] => 2009-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 94 [patent_no_of_words] => 46395 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12649179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6520017 [patent_doc_number] => 20100261885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'PEGylation by the Dock and Lock (DNL) Technique' [patent_app_type] => utility [patent_app_number] => 12/644146 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9039 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261885.pdf [firstpage_image] =>[orig_patent_app_number] => 12644146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007858 [patent_doc_number] => 20110059889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn' [patent_app_type] => utility [patent_app_number] => 12/641844 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 36761 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059889.pdf [firstpage_image] =>[orig_patent_app_number] => 12641844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574632 [patent_doc_number] => 20100129364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/641270 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 31611 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129364.pdf [firstpage_image] =>[orig_patent_app_number] => 12641270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8442483 [patent_doc_number] => 20120259099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'METHOD FOR MANUFACTURING DIMERS AND MULTIMERS BY INCREASING THE PRODUCTION OF BOND BRIDGES IN A COMPLEX OF MULTIPLE MONOMERS AND REPEATING CHAINS OF AN ADHEREND OF A TYPE SPECIFICALLY ADHERING TO MONOMERS' [patent_app_type] => utility [patent_app_number] => 13/516367 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7532 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6454670 [patent_doc_number] => 20100189727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Masking Ligands For Reversible Inhibition Of Multivalent Compounds' [patent_app_type] => utility [patent_app_number] => 12/633102 [patent_app_country] => US [patent_app_date] => 2009-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8837 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189727.pdf [firstpage_image] =>[orig_patent_app_number] => 12633102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9762297 [patent_doc_number] => 08846621 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Compositions and methods for treating diseases associated with angiogenesis and inflammation' [patent_app_type] => utility [patent_app_number] => 12/628592 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 9484 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12628592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566984 [patent_doc_number] => 20110287047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'CROSS-BETA STRUCTURES AS CARRIER IN VACCINES' [patent_app_type] => utility [patent_app_number] => 12/998691 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23424 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287047.pdf [firstpage_image] =>[orig_patent_app_number] => 12998691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6504131 [patent_doc_number] => 20100260760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'HUMAN ANTI-VEGF POLYCLONAL ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/617603 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9317 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260760.pdf [firstpage_image] =>[orig_patent_app_number] => 12617603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766166 [patent_doc_number] => 20120034223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'METHODS OF IMPROVING THE THERAPEUTIC EFFICACY AND UTILITY OF ANTIBODY FRAGMENTS' [patent_app_type] => utility [patent_app_number] => 13/127926 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 32674 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034223.pdf [firstpage_image] =>[orig_patent_app_number] => 13127926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4431670 [patent_doc_number] => 07968313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Selection of cells expressing heteromeric polypeptides' [patent_app_type] => utility [patent_app_number] => 12/614300 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8394 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968313.pdf [firstpage_image] =>[orig_patent_app_number] => 12614300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656420 [patent_doc_number] => 20110305689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'TREATMENT OF CHRONIC INFLAMMATORY RESPIRATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/127876 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16875 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305689.pdf [firstpage_image] =>[orig_patent_app_number] => 13127876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8801895 [patent_doc_number] => 08440167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Multimodal imaging of atherosclerotic plaque targeted to LOX-1' [patent_app_type] => utility [patent_app_number] => 13/126029 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 11388 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440231 [patent_doc_number] => 20100279399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Human Cancer Stem Cell Culture Compositions Comprising ErbB2 Variants and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/604942 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21232 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279399.pdf [firstpage_image] =>[orig_patent_app_number] => 12604942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202335 [patent_doc_number] => 20110065121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'METHOD FOR THE DETECTION OF APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 12/604212 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13842 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065121.pdf [firstpage_image] =>[orig_patent_app_number] => 12604212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026101 [patent_doc_number] => 08535681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Sustained drug delivery system' [patent_app_type] => utility [patent_app_number] => 13/124654 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 9042 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6608791 [patent_doc_number] => 20100099201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'METHODS AND COMPOSITIONS RELATING TO ISOCYANATE CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/577241 [patent_app_country] => US [patent_app_date] => 2009-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11542 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099201.pdf [firstpage_image] =>[orig_patent_app_number] => 12577241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6573911 [patent_doc_number] => 20100129314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'POTENT CONJUGATES AND HYDROPHILIC LINKERS' [patent_app_type] => utility [patent_app_number] => 12/574466 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 22791 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129314.pdf [firstpage_image] =>[orig_patent_app_number] => 12574466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479738 [patent_doc_number] => 20100092495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'POTENT CELL-BINDING AGENT DRUG CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/574430 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8901 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092495.pdf [firstpage_image] =>[orig_patent_app_number] => 12574430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6413157 [patent_doc_number] => 20100166802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'METHODS AND REAGENTS FOR DECREASING CLINICAL REACTION TO ALLERGY' [patent_app_type] => utility [patent_app_number] => 12/572599 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 51691 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166802.pdf [firstpage_image] =>[orig_patent_app_number] => 12572599 [rel_patent_id] =>[rel_patent_doc_number] =>)